The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...

XARELTO (rivaroxaban) 20mg tablets Janssen Pharmaceuticals announced FDA approval of Xarelto (rivaroxaban) tablets for the prevention of deep vein thrombosis (DVT) that may lead to a pulmonary ...

Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban ...

Indoco Remedies Ltd., a fully integrated, research-oriented pharmaceutical company, announced final approval of the company’s Abbreviated New Drug Application (ANDA) for rivaroxaban tablets USP, 2.5 ...

Biocon Pharma has received US FDA approvals for Lenalidomide capsules and Dasatinib tablets, with tentative approval for Rivaroxaban tablets. Coforge has partnered with Sabre Corporation to accelerate ...

Alembic Pharma share price touched all-time high today after the company announced that it has received tentative approval from US Food & Drug Administration (USFDA) for Rivaroxaban Tablets. Alembic ...

Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5mg, the generic equivalent of Janssen ...

Citing IQVIA data, Alembic Pharmaceuticals said Rivaroxaban tablets, 10 mg, 15 mg, and 20 mg have an estimated market size of USD 6.1 billion for the 12 months period ending March 2020. Alembic now ...

Grenoble, France - With the long-awaited advents of rivaroxaban (Xarelto, Bayer/Johnson & Johnson), apixaban (Eliquis, Pfizer/Bristol-Myers Squibb), and dabigatran (Pradaxa, Boehringer Ingelheim) as ...